Mark Leong – Executive Chairman – Osteopore (ASX:OSX) is a Singapore-headquartered corporation poised to be a leading medical device company in the region. It is involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Copyright 2023 – Finance News Network
18 Sep 2024 - Venkata Gutta, CEO and Founder of MILLIBEAM, discusses the company’s mission to make millimetre-wave technology cost-effective and scalable.
18 Dec 2019 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack, provides an update on the company's Arcadia lithium project in Zimbabwe, including advanced negotiations with a number of African and international banks on funding.
05 May 2022 - Torian Resources Limited (ASX:TNR) Executive Chairman Paul Summers and Senior Geologist Claudio Sheriff discuss the significance of the company's rare earths discovery.
05 Dec 2019 - Memphasys Limited (ASX:MEM) Executive Chairman, Alison Coutts talks about progress with the company's human assisted reproductive device for the separation of sperm cells in IVF clinics.
17 Aug 2022 - CARETEQ Limited (ASX:CTQ) Executive Chairman Mark Simari discusses the company's recent agreement with drug management platform StrongRoom AI and the transition from paper-based to digital record keeping within the aged care and assistive living sector.
07 Oct 2022 - Stealth Global Holdings Limited (ASX:SGI) Group Managing Director Michael Arnold discusses the business offering, M&A activity, clients, 2025 strategy and financial targets.
12 Aug 2020 - Centuria Capital Group (ASX:CNI) Joint CEO John McBain discusses full year 2020 results, acquisition of Augusta Capital, and guidance for FY21.
19 Jun 2024 - Steve Prendeville, Founder and Director of Forte Asset Solutions, speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). The discussion touches on the market for financial practices, what advisors can do to prepare their business for sale and what to look out for when acquiring a business, among many other topics.
30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.